We Create the Future of Health.

We are BICO

We provide the Life Science industry with next generation technologies that extend the boundaries of what’s possible to give people better and healthier lives.

Bico by numbers

  • Net sales Q1-Q3, 2021
    0 MUSD
  • Organic growth Q1-Q3, 2021
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +

press releases

Industry Leaders Shaping the Future of Health With Our Products

The future of global healthcare

Bio Convergence

The lines between biology, engineering, nanotech, and IT are becoming increasingly blurred. The next generation of healthcare solutions aren’t just inspired by nature. They actively incorporate biological systems and processes, unlocking possibilities that were unthinkable just a few years ago.

How We Revolutionize Science

With over 25,000 instruments in the field, our products are used in more than 2,500 laboratories across the world’s top 20 leading pharmaceutical companies and academic institutions our products are enabling scientists to make seismic changes in their fields. With citations in over 9,500 publications spanning more than 65 countries, together with our customers we are shaping the future of health. Click here to read about the groundbreaking research being done today.

Making the Seemingly Impossible, Possible

Focusing on tissue engineering, multiomics, cell line development and diagnostics, we enable researchers to grow cells in 3D environments, conduct high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries.

How We Revolutionize Science

With over 25,000 instruments in the field, our products are used in more than 2,500 laboratories across the world’s top 20 leading pharmaceutical companies and academic institutions our products are enabling scientists to make seismic changes in their fields. With citations in over 9,500 publications spanning more than 65 countries, together with our customers we are shaping the future of health. Click here to read about the groundbreaking research being done today.

Making the Seemingly Impossible, Possible

Focusing on tissue engineering, multiomics, cell line development and diagnostics, we enable researchers to grow cells in 3D environments, conduct high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries.

How We Revolutionize Science

With over 25,000 instruments in the field, our products are used in more than 2,500 laboratories across the world’s top 20 leading pharmaceutical companies and academic institutions our products are enabling scientists to make seismic changes in their fields. With citations in over 9,500 publications spanning more than 65 countries, together with our customers we are shaping the future of health. Click here to read about the groundbreaking research being done today.

Making the Seemingly Impossible, Possible

Focusing on tissue engineering, multiomics, cell line development and diagnostics, we enable researchers to grow cells in 3D environments, conduct high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries.

Subsidiaries

Business areas

Calendar

02/23/22Year-end report 2021
03/16/22Annual report 2021
04/26/22Annual General Meeting 2022
05/18/22Interim report January-March 2022

BICO in the press

12/17/21 Genetic Engineering & Biotechnology NewsBICO Group Expands into Software with Up-to-$165M Biosero Acquisition
12/16/21 3D Printing Media NetworkBICO Endorses FDA Modernization Act of 2021
11/26/21 Nordic Life Science NewsThese are the 5 nominees for the SwedenBIO Award
09/01/21 Genetic Engineering & Biotechnology NewsBuying Spree: Rebranded BICO Bets Big on “Bioconvergence”
08/31/21 San Diego Business JournalAdvanced BioMatrix Acquired by BICO for $15M
08/20/21 Nordic Life Science NewsCELLINK rebrands itself to BICO